Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 98

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 98
---
 |

| · | to change anything that does not materially adversely affect the interests of any holder of debt securities 
 of any series issued pursuant to such indenture.                                                            |

In addition, under the indentures,
the rights of holders of a series of debt securities may be changed by us and the debenture trustee with the written consent of the holders
of at least a majority in aggregate principal amount of the outstanding debt securities of each series (or, at a meeting of holders of
such series at which a quorum is present, the holders of a majority in principal amount of the debt securities of such series represented
at such meeting) that is affected. However, the debenture trustee and we may make the following changes only with the consent of each
holder of any outstanding debt securities affected:

| · | extending the fixed maturity of the series of debt securities; |

| · | reducing the principal amount, reducing the rate of or extending the time of payment of interest, or any 
 premium payable upon the redemption of any debt securities;                                              |

| 54 |

| · | reducing the principal amount of discount securities payable upon acceleration of maturity; |

| · | making the principal of or premium or interest on any debt security payable in currency other than that 
 stated in the debt security; or                                                                         |

| · | reducing the percentage of debt securities, the holders of which are required to consent to any amendment 
 or waiver.                                                                                                |

Except for certain specified
provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series (or, at a meeting
of holders of such series at which a quorum is present, the holders of a majority in principal amount of the debt securities of such series
represented at such meeting) may on behalf of the holders of all debt securities of that series waive our compliance with provisions of
the indenture. The holders of a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders
of all the debt securities of such series waive any past default under the indenture with respect to that series and its consequences,
except a default in the payment of the principal of, premium or any interest on any debt security of that series or in respect of a covenant
or provision, which cannot be modified or amended without the consent of the holder of each outstanding debt security of the series affected;
provided, however, that the holders of a majority in principal amount of the outstanding debt securities of any series may
rescind an